Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides

Keyphrases

• Antiserum 100%
• D2 Dopamine Receptor 100%
• Sequence Specificity 100%
• Specific Peptide 100%
• 125I 42%
• D2 Receptor 42%
• Caudate 42%
• Canine 28%
• Binding Site 28%
• Anti-peptide Antibody 28%
• Third Intracellular Loop 28%
• High Affinity 14%
• Immunostaining 14%
• Complementary DNA (cDNA) 14%
• Striatum 14%
• Rat Brain 14%
• Hypothalamus 14%
• Immunoblot 14%
• Titer 14%
• Immunohistochemical Study 14%
• Striatal 14%
• Nucleus Accumbens 14%
• G Protein 14%
• Immunoreactivity 14%
• Dopamine Receptor 14%
• Radioimmunoassay 14%
• High-affinity Binding 14%
• Synthetic Peptides 14%
• Potential Determinants 14%
• Immunogenicity 14%
• Immunoprecipitation Assay 14%
• Immune Serum 14%
• Digitonin 14%
• Immunogen 14%
• Receptor Isoforms 14%
• Immunological Methods 14%
• Keyhole Limpet Hemocyanin 14%
• Solid Phase 14%
• Ventral Pallidum 14%
• Immunoprecipitates 14%
• 293 Cells 14%
• Multiple Bands 14%
• Pre-immune 14%
• Protein Coupling 14%
• Primary Immunization 14%

Neuroscience

• Antiserum 100%
• Dopamine Receptor D2 100%
• Receptor Antibody 100%
• Eicosanoid Receptor 75%
• Iodine-125 37%
• Binding Site 25%
• Immunoprecipitation 25%
• Agonist 12%
• Immunohistochemistry 12%
• Western Blot 12%
• Complementary DNA 12%
• Striatum 12%
• Hypothalamus 12%
• G Protein 12%
• Staining Technique 12%
• Binding Affinity 12%
• Nucleus Accumbens 12%
• Radioimmunoassay 12%
• Dopamine Receptor 12%
• Synthetic Peptide 12%
• Digitonin 12%
• Antigen 12%
• Ventral Pallidum 12%
• Keyhole Limpet Hemocyanin 12%